These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 19675395

  • 1. Challenges of introducing vaginal microbicides in India.
    Joshi S, Kulkarni V, Paranjape R, Chandhiok N.
    Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395
    [No Abstract] [Full Text] [Related]

  • 2. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL, Hart CW.
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [Abstract] [Full Text] [Related]

  • 3. Specific microbicides in the prevention of HIV infection.
    Kelly CG, Shattock RJ.
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [Abstract] [Full Text] [Related]

  • 4. [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].
    Han L, Wu ZL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):196-8. PubMed ID: 19565887
    [No Abstract] [Full Text] [Related]

  • 5. The slow evolution of microbicides for STD/HIV prevention.
    Howes J, Bass M.
    J Gend Specif Med; 1999 Feb; 2(3):22-3. PubMed ID: 11252848
    [No Abstract] [Full Text] [Related]

  • 6. Female controlled methods of contraception and sexually transmitted infections including HIV in Malawi: examining the role of the female condom and microbicides.
    Bisika T.
    East Afr J Public Health; 2009 Aug; 6(2):223-5. PubMed ID: 20000034
    [No Abstract] [Full Text] [Related]

  • 7. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK, Vanham G.
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract] [Full Text] [Related]

  • 8. Potential of vaginal microbicides in HIV control.
    Stone A.
    J R Soc Med; 2004 Mar; 97(3):158. PubMed ID: 14996989
    [No Abstract] [Full Text] [Related]

  • 9. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
    Joglekar NS, Joshi SN, Deshpande SS, Parkhe AN, Katti UR, Mehendale SM.
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
    [Abstract] [Full Text] [Related]

  • 10. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S.
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [Abstract] [Full Text] [Related]

  • 11. Measurement of microbicide acceptability among U.S. adolescent girls.
    Short MB, Perfect MM, Auslander BA, Devellis RF, Rosenthal SL.
    Sex Transm Dis; 2007 Jun; 34(6):362-6. PubMed ID: 17038964
    [Abstract] [Full Text] [Related]

  • 12. "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.
    van den Berg JJ, Rosen RK, Bregman DE, Thompson LA, Jensen KM, Kiser PF, Katz DF, Buckheit K, Buckheit RW, Morrow KM.
    AIDS Behav; 2014 May; 18(5):862-70. PubMed ID: 24248674
    [Abstract] [Full Text] [Related]

  • 13. Trials of two microbicides to be launched in Africa.
    Pincock S.
    BMJ; 2004 Apr 03; 328(7443):786. PubMed ID: 15070623
    [No Abstract] [Full Text] [Related]

  • 14. Microbicides--women pray for success.
    Bateman C.
    S Afr Med J; 2006 Jun 03; 96(6):493-4. PubMed ID: 16841128
    [No Abstract] [Full Text] [Related]

  • 15. Will vaginal microbicides solve the HIV problem in Africa?
    Muula AS.
    Croat Med J; 2006 Dec 03; 47(6):895-8. PubMed ID: 17167863
    [No Abstract] [Full Text] [Related]

  • 16. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar 03; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 17. After microbicide failures, hope that antiviral approach will gel.
    Padma TV.
    Nat Med; 2008 Apr 03; 14(4):354. PubMed ID: 18391925
    [No Abstract] [Full Text] [Related]

  • 18. Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial.
    Lacey CJ, Woodhall S, Qi Z, Sawant S, Cowen M, McCormack S, Jiang S.
    Int J STD AIDS; 2010 Oct 03; 21(10):714-7. PubMed ID: 21139151
    [Abstract] [Full Text] [Related]

  • 19. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
    Weinrib R, Browne EN, Shapley-Quinn MK, van der Straten A, Beksinska M, Mgodi N, Musara P, Mphili N, Schwartz JL, Ju S, Hanif H, Montgomery ET, Quatro Study Team.
    AIDS Behav; 2020 Feb 03; 24(2):637-647. PubMed ID: 31254190
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.